对于双特异性抗体来说是一个关键的十年?
Marlena Surowka1, Christian Klein1
1Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Roche Glycart AG, Schlieren, Switzerland.
mAbs
|March 11, 2024
概括
双特异抗体 (bsAbs) 提供了新的治疗机制. 最近的批准表明它们在治疗癌症和其他疾病方面的重要性越来越大,使它们成为关键治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 自20世纪80年代至90年代以来,单种单克隆抗体 (mAbs) 已成为治疗剂.
- 与mAbs相比,双特异性抗体 (bsAbs) 提供了新的作用机制.
- 早期开发的bsAbs显示出希望,但到2020年,只有三个被批准.
研究的目的:
- 审查最近对双特异抗体 (bsAbs) 的进展和批准.
- 突出BSAbs在瘤学和非瘤学适应症中的不断扩大的治疗应用.
- 预测bsAbs在治疗领域的未来作用.
主要方法:
- 对已批准的双特异性抗体进行文献审查.
- 对 bsAbs. 监管机构批准的分析.
- 评估已批准的bsAbs.的临床和商业成功.
主要成果:
- 自2020年以来,批准了11种新的bsAbs,其中9种用于癌症,2种用于非瘤学适应症.
- 值得注意的是,Emicizumab和Faricimab取得了显著的超级大片地位.
- 目前共有13个批准的bsAbs,表明快速增长.
结论:
- 双特异性抗体 (bsAbs) 正迅速成为必不可少的治疗方法.
- 预计在血液恶性瘤,固体瘤和非瘤领域将继续获得批准.
- bsAbs代表了治疗武器库的显著扩张.
相关概念视频
Hybridoma Technology
14.7K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.7K
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K


